Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model - Wikidata - awgldk - TriplyDB

Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model

Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model

http://www.wikidata.org/entity/Q33695186

about

Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.

P2860

Q28344748-46881394-A702-4D43-B335-E967942AD4F7 Q37625142-45B80F83-4C62-41F2-BF36-204098D86105

P2860

Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model

http://www.wikidata.org/entity/Q33695186

description

1998 nî lūn-bûn

@nan

1998 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

name

Drug evaluation of concurrent ...... plex infections in a rat model

@ast

Drug evaluation of concurrent ...... plex infections in a rat model

@en

type

label

Drug evaluation of concurrent ...... plex infections in a rat model

@ast

Drug evaluation of concurrent ...... plex infections in a rat model

@en

prefLabel

Drug evaluation of concurrent ...... plex infections in a rat model

@ast

Drug evaluation of concurrent ...... plex infections in a rat model

@en

P1433

Q33695186-28B4B8BA-D0E2-4820-9781-B71B5862B8A7

P1476

Q33695186-9DAF1F34-3191-4FEE-ADC6-C365357E35D6

P2093

Q33695186-53DAD949-C84E-47AB-B267-9EC3276D960D

Q33695186-6D53D144-66F0-47F7-9B55-8C9EFE12D787

Q33695186-8E0C9EF2-B14B-4ACD-8449-8AD784032C6B

Q33695186-B744B77F-289C-4FA5-8AA1-0FFAB9A8FC2D

Q33695186-B8D311E3-358B-4EC5-866D-F895EDFE92B0

Q33695186-D9A9F037-0C59-4E10-873B-A3A4E6199C36

Q33695186-FB222C03-E3A2-4C31-8012-F9431933E2FC

P2860

Q33695186-0F145A37-47DF-482D-A0F6-169DE21A8A40

Q33695186-166F1C8F-8729-4B37-AAA0-1CF991C71402

Q33695186-182C8089-00B3-43B1-9678-A6146E70C939

Q33695186-23149B59-FA38-489C-AEE1-6D5ADB18F60E

Q33695186-363B6732-1B16-4E55-97C1-31C1D531D1E9

Q33695186-3867893C-4E77-4C3B-9593-48B645231C87

Q33695186-4253DA7C-9863-4358-BA9A-24F021949076

Q33695186-43A9C694-B7A8-4E7C-9A51-3559D57EB978

Q33695186-4D424468-DE89-471A-ABCB-9D9FB4B66167

Q33695186-6D2C7541-B451-4941-9089-0111AA36545F

P304

Q33695186-14923133-A21C-4852-9510-40CE6E2E7DAA

P31

Q33695186-67196FED-3826-402C-93A8-F13FE6A79818

P356

Q33695186-9F6D52E5-D1DC-429C-B27D-2B56F9C3815E

P407

Q33695186-37753917-8338-4A45-B657-307501475AAA

P433

Q33695186-374D2B7D-89E2-4412-914A-0398AA090B9B

P478

Q33695186-7F9F600F-230C-400C-9BAA-DBD59FEE105F

P577

Q33695186-DAFCCF21-5022-444D-BEB9-83320BE9F554

P698

Q33695186-7495D6D5-8FF2-4EAC-A3FD-DF345757CBD7

P921

Q33695186-50EBDCBF-84A3-43C9-9C11-482C32E5959E

P932

Q33695186-5BC2ED29-851C-4AEA-95CB-FF8338A0A92E

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Drug evaluation of concurrent ...... plex infections in a rat model

@en

P2093

F Chau

http://www.w3.org/2001/XMLSchema#string

F Derouin

http://www.w3.org/2001/XMLSchema#string

G Bertrand

http://www.w3.org/2001/XMLSchema#string

L Garry

http://www.w3.org/2001/XMLSchema#string

M Brun-Pascaud

http://www.w3.org/2001/XMLSchema#string

P M Girard

http://www.w3.org/2001/XMLSchema#string

P Rajagopalan-Levasseur

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs

In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii

In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex

Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice

Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages

Rifabutin is active in murine models of toxoplasmosis

Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine

Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice

In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii

P304

1068-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.42.5.1068

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9593128

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

P932

105746

http://www.w3.org/2001/XMLSchema#string